+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Erythrocyte pyruvate kinase deficiency: a kinetic method for differentiation between heterozygosity and compound-heterozygosity



Erythrocyte pyruvate kinase deficiency: a kinetic method for differentiation between heterozygosity and compound-heterozygosity



American Journal of Hematology 31(4): 225-232



The goal of the present study was to search for criteria that allow one to distinguish between normal individuals and heterozygotes as well as compound heterozygotes for pyruvate kinase (PK) deficiency. As the residual activity of PK with heterozygotes was between 35% and 110% of the normal activity, it was necessary to find other methods to prove heterozygosity. The PK in the hemolysates of 23 patients suffering from PK deficiency, 36 paternal and maternal enzymes as well as the enzymes of five heterozygous and four normal siblings together with those of 20 normal individuals, were studied according to the recommendations of the International Committee for Standardization in Haematology. The following hematological and enzyme kinetic parameters can serve to identify heterozygotes for PK deficiency: 1) a slight reticulocytosis, 2) an up-to-twofold increase of the intracellular concentrations of glucose-6-phosphate in the erythrocyte, 3) a mixed cooperativity of the phosphoenolpyruvate (PEP)-binding process of PK, 4) a decreased nucleotide specificity with guanosine diphosphate and uridine diphosphate, and 5) a lowered affinity for adenosine diphosphate. The most significant criterium found with all heterozygotes was a mixed cooperativity of the PEP-binding process caused by the presence of a mixture of normal and mutant PK.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040046099

Download citation: RISBibTeXText

PMID: 2741920

DOI: 10.1002/ajh.2830310402


Related references

Compound heterozygosity in PKLR gene for a previously unrecognized intronic polymorphism and a rare missense mutation as a novel cause of severe pyruvate kinase deficiency. Haematologica 2019, 2019

Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency. Blood 80(10): 2643-2649, 1992

Electrophoretic, immunologic and kinetic characterization of erythrocyte pyruvate kinase in the Basenji dog with pyruvate kinase deficiency. Tohoku Journal of Experimental Medicine 117(2): 179-185, 1975

Kinetic properties of mutant enzymes in erythrocyte phosphofructokinase deficiency and erythrocyte pyruvate kinase deficiency. Medical Journal of Osaka University 33(3-4): 49-58, 1983

A new sickle cell disease phenotype associating heterozygosity for HbS, homozygous pyruvate kinase deficiency and an alpha2 globin gene variant. Blood 90(10 SUPPL 1 PART 1): 126A-127A, Nov 15, 1997

Chronic haemolytic anaemia in two patients heterozygous for erythrocyte pyruvate kinase deficiency. Electrofocusing and immunological studies of erythrocyte and liver pyruvate kinase. Scandinavian Journal of Haematology 16(4): 250-257, 1976

Carriers of two different Hb Fannin-Lubbock genotypes encountered in California Homozygosity for the beta119 GlyfwdarwAsp; compound heterozygosity for the beta119 GlyfwdarwAsp/beta thalassemia; and compound heterozygosity for the ValfwdarwLeu and Hb S. Blood 92(10 SUPPL 1 PART 1-2): 31B, Nov 15, 1998

Erythrocyte pyruvate kinase deficiency. A kinetic study of the membrane-localised and cytoplasmatic enzyme from six patients. Enzyme 29(3): 189-197, 1983

Erythrocyte pyruvate kinase ec 2.7.1.40 deficiency a kinetic study of the membrane localized and cytoplasmic enzyme from 6 patients. Enzyme 29(3): 189-197, 1983

Human erythrocyte pyruvate kinase deficiency: the use of a kinetic study of mutant enzymes for the detection of heterozygotes. Human Genetics 41(1): 61-72, 1978

Pyruvate kinase deficiency of the erythrocyte kinetic and electrophoretic indications of a post translational maturation disturbance. Onkologie 6(5): 256, 1983

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons. Bmc Cancer 10: 195, 2010

Rhh: an R extension for estimating multilocus heterozygosity and heterozygosity-heterozygosity correlation. Molecular Ecology Resources 10(4): 720-722, 2011

Compound heterozygosity for two novel mutations in a severe factor XI deficiency. American Journal of Hematology 73(4): 279-284, 2003

Two families with compound heterozygosity for adenine phosphoribosyltransferase deficiency. Pediatric Nephrology 25(6): 1173-1176, 2010